pI: 7.0557 |
Length (AA): 3014 |
MW (Da): 334129 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 14 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
156 | 958 | 4fdd (A) | 53 | 821 | 12.00 | 0.00000026 | 0.54 | 0.119823 | 1.13 |
1119 | 2130 | 4zj7 (A) | 28 | 1086 | 14.00 | 0 | 1 | 0.444366 | 0.39 |
1261 | 2178 | 5w0v (B) | 77 | 1059 | 12.00 | 0 | 1 | 0.369179 | 0.19 |
1446 | 2225 | 3ea5 (D) | 2 | 783 | 13.00 | 0 | 1 | 0.302392 | 0.5 |
1448 | 2170 | 5hdt (B) | 54 | 797 | 14.00 | 0 | 1 | 0.330481 | 0.35 |
1549 | 2515 | 1u6g (C) | 22 | 1066 | 14.00 | 0 | 1 | 0.405436 | 0.42 |
1574 | 1721 | 4g3a (A) | 50 | 195 | 25.00 | 0.19 | 0.97 | 0.478004 | -1.05 |
1575 | 1838 | 4xl5 (C) | 16 | 225 | 31.00 | 0.72 | 1 | 0.249491 | -0.15 |
1654 | 1882 | 4hxt (A) | 4 | 242 | 18.00 | 0 | 1 | 0.388579 | -1.21 |
1772 | 2710 | 5vch (A) | 41 | 1033 | 11.00 | 0 | 1 | 0.416146 | 0.2 |
1935 | 2203 | 4zv6 (A) | 47 | 272 | 29.00 | 0.41 | 0.97 | 0.25515 | 0.18 |
2083 | 2174 | 5xjg (A) | 49 | 139 | 20.00 | 0 | 0.43 | 0.376124 | -1.4 |
2120 | 2260 | 4u2x (D) | 340 | 489 | 18.00 | 0 | 0.98 | 0.371382 | -1.23 |
2915 | 3012 | 4jw3 (C) | 8 | 104 | 8.00 | 0.0034 | 0.01 | 0.00791493 | -0.52 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128125)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G64790 | protein ILITYHIA |
Babesia bovis | BBOV_II003920 | HEAT repeat family protein |
Brugia malayi | Bm1_44525 | HsGCN1 |
Candida albicans | CaO19.5328 | N terminus is frameshifted into CaP19.5333 upstream |
Candida albicans | CaO19.12793 | similar to N terminus of S. cerevisiae GCN1 (YGL195W) translational activator of GCN4 via activation of eIF2alpha kinase GCN2 in |
Candida albicans | CaO19.12788 | N terminus is frameshifted into CaP19.12793 upstream |
Candida albicans | CaO19.5333 | similar to N terminus of S. cerevisiae GCN1 (YGL195W) translational activator of GCN4 via activation of eIF2alpha kinase GCN2 in |
Caenorhabditis elegans | CELE_Y48G9A.3 | Protein GCN-1 |
Cryptosporidium hominis | Chro.80225 | hypothetical protein |
Cryptosporidium parvum | cgd8_1930 | large protein with a GCN1 domain |
Dictyostelium discoideum | DDB_G0279487 | GCN1-like protein |
Drosophila melanogaster | Dmel_CG17514 | CG17514 gene product from transcript CG17514-RA |
Echinococcus granulosus | EgrG_000967600 | translational activator gcn1 |
Entamoeba histolytica | EHI_078260 | HEAT repeat domain containing protein |
Echinococcus multilocularis | EmuJ_000967600 | translational activator gcn1 |
Homo sapiens | ENSG00000089154 | GCN1 general control of amino-acid synthesis 1-like 1 (yeast) |
Leishmania braziliensis | LbrM.18.0910 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_180820.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.18.0820 | hypothetical protein, conserved |
Leishmania major | LmjF.18.0820 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.18.0820 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_02023 | hypothetical protein |
Mus musculus | ENSMUSG00000041638 | GCN1 general control of amino-acid synthesis 1-like 1 (yeast) |
Neospora caninum | NCLIV_031730 | translational activator, putative |
Oryza sativa | 4333935 | Os03g0721200 |
Saccharomyces cerevisiae | YGL195W | Gcn1p |
Schistosoma japonicum | Sjp_0111150 | expressed protein |
Schistosoma japonicum | Sjp_0124290 | IPR000357,HEAT,domain-containing |
Schistosoma japonicum | Sjp_0007570 | Translational activator GCN1, putative |
Schistosoma mansoni | Smp_134860 | translational activator gcn1-related |
Schistosoma mansoni | Smp_075950 | hypothetical protein |
Schmidtea mediterranea | mk4.006229.01 | Translational activator GCN1 |
Schmidtea mediterranea | mk4.006229.00 | Translational activator GCN1 |
Schmidtea mediterranea | mk4.012988.00 | |
Trypanosoma brucei gambiense | Tbg972.10.16050 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.13280 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_10_11380 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_10_11370 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.508891.130 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.503681.9 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.506357.130 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_231480 | GCN1, putative |
Trichomonas vaginalis | TVAG_458760 | translational activator gcn1, putative |
Trichomonas vaginalis | TVAG_417700 | translational activator gcn1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.13280 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.13280 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.13280 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.13280 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_231480 | Toxoplasma gondii | Essentiality uncertain | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.